Si-Bone (SIBN) Invested Capital (2019 - 2022)
Si-Bone's (SIBN) quarterly Invested Capital came in at $1.5 million in Q3 2022, down 83.3% quarter-over-quarter from $8.7 million in Q1 2020.
Si-Bone (SIBN) Invested Capital (2019 - 2022) Analysis & Trends
Si-Bone's Invested Capital history runs 3 years deep, the most recent figure standing at $1.5 million for Q3 2022.
- On a quarterly basis, Invested Capital changed N/A year-over-year to $1.5 million in Q3 2022; TTM through Jun 2023 was $1.5 million, a N/A change from a year earlier, with the FY2019 full-year figure at $4.4 million, changed N/A from the prior year.
- Invested Capital fell to $1.5 million in Q3 2022 per SIBN's latest filing, from $8.7 million in the prior quarter.
- Across five years, Invested Capital topped out at $8.7 million in Q1 2020 and bottomed at $1.5 million in Q3 2022.
- The 3-year median for Invested Capital is $4.4 million (2019), against an average of $4.8 million.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 4.41 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 499.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.79 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 1.41 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 7.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 15.00 Mn |
| 10 | Si-Bone | 724.02 Mn | 579.33 Mn | 41.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 1.46 Mn |
| Mar 31, 2020 | 8.73 Mn |
| Dec 31, 2019 | 4.36 Mn |